Literature DB >> 1600267

Exacerbation of hypothyroidism following tumor necrosis factor-alpha infusion.

H Miyakoshi1, K Ohsawa, H Yokoyama, Y Nagai, Y Ieki, Y I Bando, K Kobayashi.   

Abstract

A 46-year-old woman with chronic thyroiditis who had been receiving thyroid hormone treatment for 10 yr developed severe hypothyroidism (FT4 0.37 ng/dl, FT3 1.38 pg/ml, TSH 151.00 microU/ml) following tumor necrosis factor-alpha (TNF) infusion for the treatment of a complicated cutaneous T-cell lymphoma. Indirect immunofluorescence staining of thyroid follicular cells showed aberrant expression of HLA class II antigens. The mechanisms underlying the exacerbation of the hypothyroidism may be an augmentation of immunological processes in the thyroid and a direct action of TNF on the synthesis and secretion of thyroid hormone.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600267     DOI: 10.2169/internalmedicine.31.200

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Thyroid involvement in ankylosing spondylitis and relationship of thyroid dysfunction with anti-TNF α treatment.

Authors:  Figen Tarhan; Gonca Orük; Ozgür Niflioğlu; Serhat Ozer
Journal:  Rheumatol Int       Date:  2012-05-22       Impact factor: 2.631

2.  Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism.

Authors:  Wade T Iams; Megan L Hames; Judy P Tsai; Kimberly B Dahlman; Mahsa S Talbott; Kristy L Richards; Nishitha M Reddy
Journal:  Exp Hematol       Date:  2014-10-28       Impact factor: 3.084

3.  Infliximab can induce a prolonged clinical remission and a decrease in thyroid hormonal requirements in a patient with SAPHO syndrome and hypothyroidism.

Authors:  Francisca Sabugo; Claudio Liberman; Juan Pablo Niedmann; Lilian Soto; Miguel Cuchacovich
Journal:  Clin Rheumatol       Date:  2007-10-16       Impact factor: 2.980

4.  Infliximab-Induced Hypothyroidism: A Novel Case and Postulations concerning the Mechanism.

Authors:  Brett Cerniglia; Marc A Judson
Journal:  Case Rep Med       Date:  2013-11-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.